SARAH LYNCH: Open Payments
NPI 1669013595 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 10 payments from 8 companies in 2025. Trend: 2023 $1,184 · 2024 $1,388 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $64 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Almatica Pharma LLC | 1 | $29 |
| Alkermes, Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: INGREZZA, CAPLYTA, Auvelity, LOREEV XR, ARISTADA, REXULTI, AUSTEDO XR, FANAPT.
Industry payments across FL — which companies pay providers there.
